66 related articles for article (PubMed ID: 29284000)
1. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes.
Morgan JL; Shrestha A; Reed MWR; Herbert E; Bradburn M; Walters SJ; Martin C; Collins K; Ward S; Holmes G; Burton M; Lifford K; Edwards A; Ring A; Robinson T; Chater T; Pemberton K; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Thomson AM; Gosney M; Hatton M; Green T; Revill D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeschwar R; Wyld L
Br J Surg; 2021 Apr; 108(3):315-325. PubMed ID: 33760065
[TBL] [Abstract][Full Text] [Related]
2. Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer.
Morgan JL; Holmes G; Ward S; Martin C; Burton M; Walters SJ; Cheung KL; Audisio RA; Reed MW; Wyld L;
Eur J Surg Oncol; 2021 Feb; 47(2):261-268. PubMed ID: 33046279
[TBL] [Abstract][Full Text] [Related]
3. Management of early breast cancer in older women: from screening to treatment.
Elomrani F; Zine M; Afif M; L'annaz S; Ouziane I; Mrabti H; Errihani H
Breast Cancer (Dove Med Press); 2015; 7():165-71. PubMed ID: 26185468
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression of oestrogen receptor in breast cancer: Clinical and molecular significance.
Makhlouf S; Quinn C; Toss M; Alsaleem M; Atallah NM; Ibrahim A; Rutland CS; Mongan NP; Rakha EA
Eur J Cancer; 2024 Jan; 197():113473. PubMed ID: 38103327
[TBL] [Abstract][Full Text] [Related]
5. Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women.
Carleton N; Nasrazadani A; Gade K; Beriwal S; Barry PN; Brufsky AM; Bhargava R; Berg WA; Zuley ML; van Londen GJ; Marroquin OC; Thull DL; Mai PL; Diego EJ; Lotze MT; Oesterreich S; McAuliffe PF; Lee AV
Lancet Healthy Longev; 2022 Jan; 3(1):e54-e66. PubMed ID: 35047868
[TBL] [Abstract][Full Text] [Related]
6. Adequate Assessment Can Affect the Management of Breast Cancer in Geriatric Population.
Monib S; Elkorety M; Habashy H
Indian J Surg Oncol; 2021 Dec; 12(4):785-791. PubMed ID: 35110902
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients.
Richman J; Schuster G; Buus R; Lopez-Knowles E; Dowsett M
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38709373
[TBL] [Abstract][Full Text] [Related]
8. Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?
Chua GWY; Li L
Breast Care (Basel); 2024 Apr; 19(2):106-115. PubMed ID: 38645759
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Outcome: What Have We Achieved.
Möbus V; Schmidt M
Breast Care (Basel); 2023 Dec; 18(6):419-421. PubMed ID: 38125922
[No Abstract] [Full Text] [Related]
10. Lacidophilin tablets alleviate constipation through regulation of intestinal microflora by promoting the colonization of Akkermansia sps.
Sun D; Yu J; Zhan Y; Cheng X; Zhang J; Li Y; Li Q; Xiong Y; Liu W
Sci Rep; 2024 Mar; 14(1):7152. PubMed ID: 38531966
[TBL] [Abstract][Full Text] [Related]
11. Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome.
Parks RM; Albanghali M; Syed BM; Green AR; Ellis IO; Cheung KL
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726924
[TBL] [Abstract][Full Text] [Related]
12. Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL
PLoS One; 2018; 13(1):e0191979. PubMed ID: 29370282
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL
PLoS One; 2017; 12(12):e0188528. PubMed ID: 29284000
[TBL] [Abstract][Full Text] [Related]
14. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre.
Syed BM; Al-Khyatt W; Johnston SJ; Wong DW; Winterbottom L; Kennedy H; Green AR; Morgan DA; Ellis IO; Cheung KL
Br J Cancer; 2011 Apr; 104(9):1393-400. PubMed ID: 21448163
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
17. Early primary breast cancer in the elderly - pattern of presentation and treatment.
Tang SW; Parker H; Winterbottom L; Hassell K; Ellis IO; Morgan DA; Cheung KL
Surg Oncol; 2011 Mar; 20(1):7-12. PubMed ID: 19679464
[TBL] [Abstract][Full Text] [Related]
18. The curability of breast cancer and the treatment of advanced disease.
Guarneri V; Conte PF
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
